Christopher P. Kiritsy - Jun 25, 2021 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
Director
Signature
/s/ Marc D. Mantell, Attorney-in-fact
Stock symbol
PIRS
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/29/2021, 05:30 PM
Next filing
Jan 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 25, 2021 Common Stock 40K $4.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to 100% of the underlying shares on the date of the Company's 2022 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.